Sage Therapeutics Reports Disappointing Study Results for Alzheimer’s Treatment
In This Article:
The biopharmaceutical company isn’t planning further clinical development of dalzanemdor to treat Alzheimer’s.
The biopharmaceutical company isn’t planning further clinical development of dalzanemdor to treat Alzheimer’s.